Respiratory Syncytial Virus (RSV) Infection News

Quidel Corp (QDEL) Announces FDA Clearance for Its Solana RSV + hMPV Assay - StreetInsider.com



Quidel Corp (QDEL) Announces FDA Clearance for Its Solana RSV + hMPV Assay 
StreetInsider.com
... (FDA) to market its Solana® respiratory syncytial virus (?RSV?) + human metapneumovirus (?hMPV?) Assay for the detection of nucleic acids isolated from nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection to ...
Quidel's Solana RSV/hMPV Test Clears FDA GenomeWeb

all 2 news articles » 


News Scan for Oct 17, 2017 - CIDRAP



News Scan for Oct 17, 2017 
CIDRAP
Caribbean and Central American countries reported low activity in general, but respiratory syncytial virus (RSV) activity remained high in several countries. In temperate ... They published their findings in an Oct 13 letter to the Journal of Infection ...

 


VirionHealth secures Abingworth backing to trial novel antiviral studies - BioPharma-Reporter.com



BioPharma-Reporter.com
 
VirionHealth secures Abingworth backing to trial novel antiviral studies 
BioPharma-Reporter.com
The UK biotech completed the series A fundraising round last week, telling us the money will pay for early clinical development of preclinical-stage candidate therapies for the treatment of influenza A and respiratory syncytial (RSV) infections ...

 


Respiratory RSV vaccine to be trialled on unborn babies - BBC News



BBC News
 
Respiratory RSV vaccine to be trialled on unborn babies 
BBC News
It aims to prevent respiratory syncytial virus (RSV) that causes about 30 baby deaths a year in the UK. The virus can cause severe infections in lung and breathing passages. It can affect people of all ages but affects almost all infants by the age of ...

and more » 


Children without allergies can still be afflicted with asthma-like coughing and wheezing - Science Daily



Children without allergies can still be afflicted with asthma-like coughing and wheezing 
Science Daily
"TRPV1 plays a critical role in the mechanism of cough, though it is not linked to immune or allergic mechanisms. Many young children cough and wheeze when they get infected by respiratory syncytial virus (RSV) -- similar to an asthma attack -- but ...

and more » 


Secondhand smoke increases inflammation risk in infants with RSV - Healio



Secondhand smoke increases inflammation risk in infants with RSV 
Healio
SAN DIEGO ? Exposing infants with respiratory syncytial virus bronchiolitis to secondhand smoke increases their risk of inflammation, while suppressing T and B cell responses, according to a recent presentation held at IDWeek 2017. ?Parents do not ...

 


Brace Yourselves For The Rise Of This Respiratory Virus - Huffington Post Canada



Huffington Post Canada
 
Brace Yourselves For The Rise Of This Respiratory Virus 
Huffington Post Canada
Scott Camazine/Ed Dubovi via Getty Images Color-enhanced transmission electron micrograph (TEM) of respiratory syncytial virus (RSV). ... Those who happen to fall in between these extremes generally have been considered to be safe from infection.

 


How seemingly acute viral infections can persist - Science Daily



Science Daily
 
How seemingly acute viral infections can persist 
Science Daily
But in some cases the effects of the infection, and presence of the virus itself, can persist. RSV, for example, can lead to chronic respiratory problems, measles can lead to encephalitis and the Ebola virus can be transmitted by patients thought to be ...

and more » 


Penn Team Shows How Seemingly Acute Viral Infections Can ... - Penn: Office of University Communications



Penn: Office of University Communications
 
Penn Team Shows How Seemingly Acute Viral Infections Can ... 
Penn: Office of University Communications
Making insights into how virus-infected cells can survive the onslaught of an immune response, researchers have found that cells enriched with defective viral ...

and more » 


FDA Publishes Antiviral Guidance | BioPharm International - BioPharm International



FDA Publishes Antiviral Guidance | BioPharm International 
BioPharm International
The agency published guidance on developing antiviral drugs to treat respiratory syncytial virus infection.

and more »